Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ACRS · against 478 other Healthcare companies of similar size
Ranked #209 of 479 · scores higher than 56% of peers · safety percentile 62
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)62 peers with a safety percentile of 60–69, including ACRS · Click a bar to see the companies
A mix: stronger debt / equity and current ratio, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | ACRS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 447 reported | 0.01× | 0.18× | 85% | 33% | |
| BetaLower is better · 458 reported | 0.88 | 0.41 | 24% | 33% | |
| Current ratioHigher is better · 474 reported | 3.46× | 2.86× | 57% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.1B USD | 100 | ||
| 2 | 1.0B USD | 99 | 35 | |
| 3 | 421M USD | 99 | 52 | |
| 4 | 397M USD | 99 | 37 | |
| 5 | 455M USD | 99 | 53 | |
| 205 | 90.1B JPY (≈$613M) | 62 | 55 | |
| 206 | 2.7B CNY (≈$383M) | 62 | 51 | |
| 207 | 5.8B CNY (≈$816M) | 62 | 45 | |
| 208 | 3.4B SAR (≈$909M) | 62 | 62 | |
| 209 | 551M USD | 62 | 20 | |
| 210 | 3.7B CNY (≈$520M) | 62 | 50 | |
| 211 | 6.8B CNY (≈$959M) | 62 | 43 | |
| 212 | 7.2B CNY (≈$1.0B) | 62 | 51 | |
| 213 | 375M USD | 62 | 46 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score